Skip to main content
. Author manuscript; available in PMC: 2021 Jul 16.
Published in final edited form as: Arch Neurol. 2010 Aug;67(8):976–979. doi: 10.1001/archneurol.2010.174

Table.

Subjects Who Responded Affirmatively to an Autonomic Symptom Questionnaire

Affirmative Responses/Total Responses, No. (%)
Symptoma Patients With MELAS
(n = 35)
Carrier Relatives
(n = 53)
Controls
(n = 16)
Dry eyes or mouth 7/35 (20) 14/53 (26) 2/16 (12)
Bouts of excessive saliva 8/35 (23)b 5/53 (9) 0/16 (0)
Any orthostatic dizziness 15/35 (43)b,c 9/52 (17) 0/16 (0)
Autonomic-pattern dizziness 10/35 (29)b,c 1/35 (3) 0/16 (0)
Standing-induced symptoms 9/31 (29)b 10/49 (20) 0/14 (0)
Excessively cold or discolored hands or feet; Raynaud phenomenon 15/34 (44)b,d 15/52 (29) 0/16 (0)
Intolerance of heat or cold 14/35 (40)b 12/53 (23) 1/16 (6)
Postprandial symptoms 17/33 (51)b,c 12/53 (23) 0/15 (0)
Unexplained abdominal pain and/or cramps 8/34 (23)b 9/53 (17) 0/16 (0)
Bouts of diarrhea 8/35 (23)b 4/53 (7) 0/16 (0)
Severe constipation 11/35 (31)b 9/53 (17) 0/16 (0)
Any gastrointestinal symptoms 23/35 (66)b,d 20/53 (38) 0/16 (0)
Bowel or bladder incontinence 10/34 (29)b 6/51 (12) 0/16 (0)
Sensation of incomplete bladder emptying 6/33 (18) 5/50 (10) 1/16 (6)
Problems with male sexual function 1/8 (12) 2/13 (15) 0/11 (0)
Pupillary dysfunction problems 14/35 (40)b,c 6/51 (12) 0/16 (0)
Any autonomic symptom 28/35 (80)b,d 33/53 (62) 2/16 (12)

Abbreviation: MELAS, mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

a

Symptoms listed are abbreviated from the complete questions posed to the subjects.

b

Significant difference between patients and controls (P < .05).

c

Significant difference between patients and carrier relatives (P < .05).

d

Significant difference between carrier relatives and controls (P < .05).